Funding & Deals Today - October 6, 2026

Arlington maritime startup raises $140M in Series B funding

Defense Startups Draw Record $40.8 Billion in Funding

Shionogi Adds to Its Rare Disease Strategy With $2B IntraBio Acquisition

Shionogi’s IntraBio acquisition brings Aqneursa, a drug approved for treating two rare neurological disorders and the potential to expand to additional indications, both rare and common. It’s Shionogi’s second big rare disease move this year, following the acquisition of global rights to an amyotrophic lateral sclerosis drug from Tanabe Pharma. The post Shionogi Adds to Its Rare Disease S…

Aimei Health Technology Extends SPAC Merger Deadline Again

The Weekly Notable Startup Funding Report: 10/5/26

IPO activity to stay strong; manufacturing, healthcare key themes: Citi's Rahul Saraf